FTVNYSETechnology

Public company intelligence preview

FORTIVE CORP

99 insider trades surfaced from the last year. This page shows only aggregate signals, not the underlying transactions, people, filings, filters, or AI workspace.

Snapshot

A narrow read on a much deeper workspace.

The preview gives search visitors enough signal to understand coverage. It does not expose transaction records, person-level profiles, filters, comparisons, or analyst workflows.

Insider trades, last 12 months
99
3 filed in the last 30 days
Acquisition / disposition count
81/18
Buy / Sell
Unique insiders active in the last year
17
Current insider positions tracked
55
51 active, 4 exited

Insider compensation

Public aggregate: $7.6M average total compensation across covered insiders.

Governance movement

Public aggregate: 3 governance events in the last year.

Institutional ownership

Public aggregate: 763 holders from the latest quarter.

Restricted sales and governance

Public counts, not the investigation layer.

The full product opens the underlying filings, insider context, historical holdings, comparison tools, and AI analysis.

Restricted-sale filings, 1Y
8
Restricted-sale insiders, 1Y
4
Planned sale shares, 1Y
136.8K
Planned sale value, 1Y
$7.7M
Insiders covered
14
Latest year: 2025
Personnel changes, 1Y
2
Board appointments, 1Y
1
Board departures, 1Y
2

Market context

Basic quote context for the preview.

Price
$58.32
Market cap
$17.8B
Volume
7,965,904
EPS
$1.73
Revenue
$4.2B
Employees
10.0K

Company note

Context before the data.

Company Overview

Fortive Corp. is a global industrial technology company in the Technology sector and the Scientific & Technical Instruments industry, focused on mission-critical tools, software, and services for manufacturing, utilities, healthcare, and other industrial end markets. Following the June 2025 spin-off of Precision Technologies, the company now centers on Intelligent Operating Solutions and Advanced Healthcare Solutions, with brands such as FLUKE, ACCRUENT, SERVICECHANNEL, and PROVATION. Its business is built around recurring workflows like maintenance, asset management, connected worker safety, sterilization, biomedical testing, and clinical productivity, which tend to support relatively durable demand. Recent results show solid pricing power and improving operating leverage, though volumes have been mixed and tariffs, FX, and healthcare-related regulation remain important operating factors.

Executive Compensation Practices

Executive compensation at Fortive is likely tied closely to core revenue growth, operating margin expansion, cash flow, and execution of portfolio actions, especially given the company’s strong emphasis on the Fortive Business System and productivity improvements. The 2025 results suggest that bonuses and long-term incentives may be influenced by pricing discipline, margin resilience, free cash flow generation, and successful management of the Precision Technologies separation, since separation-related compensation and restructuring costs were explicitly meaningful in the period. In the Scientific & Technical Instruments industry, companies often use a mix of base salary, annual incentive pay, and equity awards to reward operational efficiency, innovation, and recurring revenue growth, and Fortive’s performance metrics appear aligned with that model. Because healthcare solutions are subject to FDA and other regulatory requirements, compliance, quality, and risk management may also be embedded in executive scorecards.

Insider Trading Considerations

Insider trading activity in Fortive may be influenced by the company’s exposure to tariffs, trade policy, foreign exchange swings, healthcare regulation, and separation-related corporate events, all of which can affect near-term sentiment and reported results. The stock may see insider purchases or sales around major events such as the Precision Technologies spin-off, earnings inflection points, margin changes, or new guidance tied to pricing and volume trends in IOS and AHS. Since Fortive generates strong cash flow and continues substantial share repurchases, insiders may view buyback authorization and capital deployment as important signals about management’s confidence in intrinsic value. Researchers and traders should also watch for trading windows and restrictions around healthcare regulatory developments, M&A or portfolio actions, and quarter-end periods when results can be materially shaped by pricing, tariffs, and productivity initiatives.

Unlock the full FTV insider intelligence workspace.

Move from public aggregate counts into transaction-level detail, people, filings, compensation history, ownership shifts, export tools, and AI-assisted analysis.

Individual insider trade details with transaction history
Insider compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Restricted sale filings with details
Governance data and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
7-day free trial included
Cancel anytime
Public preview vs full product
Trade-level transactions, filing links, codes, and footnotes
Available inside the authenticated dashboard, not on the public SEO preview.
Insider pay tables with role-level and year-over-year context
Available inside the authenticated dashboard, not on the public SEO preview.
Institutional holder shifts, concentration, and quarter comparisons
Available inside the authenticated dashboard, not on the public SEO preview.
Restricted-sale, governance, AI analysis, and export workflows
Available inside the authenticated dashboard, not on the public SEO preview.